View of Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases

Return to Issue Details Selective JAK1 Inhibition Using Upadacitinib for the Management of Inflammatory Bowel Diseases Download Download PDF